IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Salix Pharmaceuticals Inc

Q3 2018 vs Q4 2018

Comparing institutional holders between quarters

Quarters

Q4 2018Q3 2018Q2 2018Q4 2017Q3 2017
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile
Cribstone Capital Management, LLC
UNCHANGED
Shares2,000 from 2,000
Change0 (0%)
Value$5 ($0)
Filed 2019-02-12
Status
Cribstone Capital Management, LLC
UNCHANGED2,0002,00000%$5$5$02019-02-12
Showing 1 of 1 institutions